Liposomal Nasal Spray versus Guideline-Recommended Steroid Nasal Spray in Patients with Chronic Rhinosinusitis: A Comparison of Tolerability and Quality of Life

Table 7

Patients’ final evaluation of efficacy and tolerability.

	Efficacy	Tolerability
Liposomal nasal spray
Very good	17.8%	39.4%
Good	53.8%	50%
Satisfactory	17.9%	7.9%
Poor	10.3%	2.6%
Beclomethasone
Very good	17.4%	26.1%
Good	47.8%	60.9%
Satisfactory	13%	4.3%
Poor	21.7%	8.7%